BMO Capital Maintains Outperform on Nuvalent, Raises Price Target to $73
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Etzer Darout has maintained an Outperform rating on Nuvalent (NASDAQ:NUVL) and raised the price target from $52 to $73.
October 05, 2023 | 12:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BMO Capital has maintained an Outperform rating on Nuvalent and raised the price target from $52 to $73.
The raised price target by BMO Capital indicates a positive outlook for Nuvalent. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100